{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T23:56:32Z","timestamp":1776815792359,"version":"3.51.2"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T00:00:00Z","timestamp":1764892800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T00:00:00Z","timestamp":1768176000000},"content-version":"vor","delay-in-days":38,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Med"],"DOI":"10.1007\/s10238-025-01866-x","type":"journal-article","created":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T12:43:23Z","timestamp":1764938603000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Integrating multi-omics data to resolve patterns of ion channel regulation in melanoma and predict tumor treatment response"],"prefix":"10.1007","volume":"26","author":[{"given":"Jiahua","family":"Xing","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muzi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ran","family":"Tao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mingyong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,5]]},"reference":[{"issue":"7621","key":"1866_CR1","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1038\/nature19364","volume":"537","author":"R Eil","year":"2016","unstructured":"Eil R, Vodnala SK, Clever D, et al. Ionic immune suppression within the tumour microenvironment limits T cell effector function. Nature. 2016;537(7621):539\u201343.","journal-title":"Nature"},{"issue":"8","key":"1866_CR2","doi-asserted-by":"publisher","first-page":"1971","DOI":"10.1016\/j.cell.2021.02.034","volume":"184","author":"M Levin","year":"2021","unstructured":"Levin M. Bioelectric signaling: reprogrammable circuits underlying embryogenesis, regeneration, and cancer. Cell. 2021;184(8):1971\u201389.","journal-title":"Cell"},{"issue":"7985","key":"1866_CR3","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1038\/s41586-023-06518-2","volume":"623","author":"H Yeo","year":"2023","unstructured":"Yeo H, Mehta V, Gulati A, et al. Structure and electromechanical coupling of a voltage-gated Na(+)\/H(+) exchanger. Nature. 2023;623(7985):193\u2013201.","journal-title":"Nature"},{"issue":"12","key":"1866_CR4","doi-asserted-by":"publisher","first-page":"2021","DOI":"10.1038\/s41590-023-01656-1","volume":"24","author":"M Pruenster","year":"2023","unstructured":"Pruenster M, Immler R, Roth J, et al. E-selectin-mediated rapid NLRP3 inflammasome activation regulates S100A8\/S100A9 release from neutrophils via transient gasdermin D pore formation. Nat Immunol. 2023;24(12):2021\u201331.","journal-title":"Nat Immunol"},{"issue":"6616","key":"1866_CR5","doi-asserted-by":"publisher","DOI":"10.1126\/science.add1268","volume":"378","author":"Y Yin","year":"2022","unstructured":"Yin Y, Zhang F, Feng S, et al. Activation mechanism of the mouse cold-sensing TRPM8 channel by cooling agonist and PIP(2). Science. 2022;378(6616):eadd1268.","journal-title":"Science"},{"issue":"7","key":"1866_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2023.112696","volume":"42","author":"T Randic","year":"2023","unstructured":"Randic T, Magni S, Philippidou D, et al. Single-cell transcriptomics of NRAS-mutated melanoma transitioning to drug resistance reveals P2RX7 as an indicator of early drug response. Cell Rep. 2023;42(7):112696.","journal-title":"Cell Rep"},{"key":"1866_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.115635","volume":"168","author":"C Cammann","year":"2023","unstructured":"Cammann C, Kulla J, Wiebusch L, et al. Proteasome inhibition potentiates Kv1.3 potassium channel expression as therapeutic target in drug-sensitive and -resistant human melanoma cells. Biomed Pharmacother. 2023;168:115635.","journal-title":"Biomed Pharmacother"},{"issue":"4","key":"1866_CR8","doi-asserted-by":"publisher","DOI":"10.15252\/embr.202255069","volume":"24","author":"KF Shoji","year":"2023","unstructured":"Shoji KF, Bayet E, Leverrier-Penna S, et al. The mechanosensitive TRPV2 calcium channel promotes human melanoma invasiveness and metastatic potential. EMBO Rep. 2023;24(4):e55069.","journal-title":"EMBO Rep"},{"key":"1866_CR9","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.961695","volume":"13","author":"Y Han","year":"2022","unstructured":"Han Y, Shi Y, Chen B, et al. An ion-channel-gene-based prediction model for head and neck squamous cell carcinoma: prognostic assessment and treatment guidance. Front Immunol. 2022;13:961695.","journal-title":"Front Immunol"},{"issue":"7693","key":"1866_CR10","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1038\/nature25501","volume":"554","author":"S Mariathasan","year":"2018","unstructured":"Mariathasan S, Turley SJ, Nickles D, et al. TGF\u03b2 attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells. Nature. 2018;554(7693):544\u20138.","journal-title":"Nature"},{"issue":"1","key":"1866_CR11","doi-asserted-by":"publisher","first-page":"1897","DOI":"10.1038\/s41467-020-15726-7","volume":"11","author":"JH Lee","year":"2020","unstructured":"Lee JH, Shklovskaya E, Lim SY, et al. Transcriptional downregulation of MHC class I and melanoma de- differentiation in resistance to PD-1 inhibition. Nat Commun. 2020;11(1):1897.","journal-title":"Nat Commun"},{"issue":"1","key":"1866_CR12","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.hoc.2018.09.005","volume":"33","author":"RI Hartman","year":"2019","unstructured":"Hartman RI, Lin JY. Cutaneous melanoma-a review in detection, staging, and management. Hematol Oncol Clin North Am. 2019;33(1):25\u201338.","journal-title":"Hematol Oncol Clin North Am"},{"issue":"2","key":"1866_CR13","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1016\/j.bbamcr.2013.10.021","volume":"1843","author":"MW Berchtold","year":"2014","unstructured":"Berchtold MW, Villalobo A. The many faces of calmodulin in cell proliferation, programmed cell death, autophagy, and cancer. Biochim Biophys Acta. 2014;1843(2):398\u2013435.","journal-title":"Biochim Biophys Acta"},{"issue":"1","key":"1866_CR14","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1186\/s12885-017-3317-2","volume":"17","author":"J Fang","year":"2017","unstructured":"Fang J, Li X, Ma D, et al. Prognostic significance of tumor infiltrating immune cells in oral squamous cell carcinoma. BMC Cancer. 2017;17(1):375.","journal-title":"BMC Cancer"},{"issue":"6230","key":"1866_CR15","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1126\/science.aaa6204","volume":"348","author":"JA Joyce","year":"2015","unstructured":"Joyce JA, Fearon DT. T cell exclusion, immune privilege, and the tumor microenvironment. Science. 2015;348(6230):74\u201380.","journal-title":"Science"},{"issue":"6","key":"1866_CR16","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1158\/2326-6066.CIR-17-0117","volume":"5","author":"D Gurusamy","year":"2017","unstructured":"Gurusamy D, Clever D, Eil R, et al. Novel \u201cElements\u201d of Immune Suppression within the Tumor Microenvironment. Cancer Immunol Res. 2017;5(6):426\u201333.","journal-title":"Cancer Immunol Res"},{"issue":"1","key":"1866_CR17","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1158\/0008-5472.CAN-16-2372","volume":"77","author":"AA Chimote","year":"2017","unstructured":"Chimote AA, Hajdu P, Sfyris AM, et al. Kv1.3 channels mark functionally competent CD8+ tumor-infiltrating lymphocytes in head and neck cancer. Cancer Res. 2017;77(1):53\u201361.","journal-title":"Cancer Res"},{"key":"1866_CR18","doi-asserted-by":"publisher","DOI":"10.1126\/scisignal.aaq1616","author":"AA Chimote","year":"2018","unstructured":"Chimote AA, Balajthy A, Arnold MJ, et al. A defect in KCa3.1 channel activity limits the ability of CD8(+) T cells from cancer patients to infiltrate an adenosine-rich microenvironment. Sci Signal. 2018. https:\/\/doi.org\/10.1126\/scisignal.aaq1616.","journal-title":"Sci Signal"},{"issue":"9","key":"1866_CR19","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0238529","volume":"15","author":"JE Rayner","year":"2020","unstructured":"Rayner JE, Duffy DL, Smit DJ, et al. Germline and somatic albinism variants in amelanotic\/hypomelanotic melanoma: increased carriage of TYR and OCA2 variants. PLoS ONE. 2020;15(9):e0238529.","journal-title":"PLoS ONE"},{"issue":"1","key":"1866_CR20","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.jdermsci.2012.09.016","volume":"69","author":"JE Hawkes","year":"2013","unstructured":"Hawkes JE, Cassidy PB, Manga P, et al. Report of a novel OCA2 gene mutation and an investigation of OCA2 variants on melanoma risk in a familial melanoma pedigree. J Dermatol Sci. 2013;69(1):30\u20137.","journal-title":"J Dermatol Sci"},{"issue":"22","key":"1866_CR21","doi-asserted-by":"publisher","first-page":"3147","DOI":"10.1080\/15384101.2019.1669998","volume":"18","author":"X Liu","year":"2019","unstructured":"Liu X, Wang B, Sun Y, et al. Astragalus root extract inhibits retinal cell apoptosis and repairs damaged retinal neovascularization in retinopathy of prematurity. Cell Cycle. 2019;18(22):3147\u201359.","journal-title":"Cell Cycle"},{"key":"1866_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.exer.2014.10.010","volume":"129","author":"CJ Locke","year":"2014","unstructured":"Locke CJ, Congrove NR, Dismuke WM, et al. Controlled exosome release from the retinal pigment epithelium in situ. Exp Eye Res. 2014;129:1\u20134.","journal-title":"Exp Eye Res"},{"issue":"2","key":"1866_CR23","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/j.jid.2016.09.022","volume":"137","author":"E De Filippo","year":"2017","unstructured":"De Filippo E, Schiedel AC, Manga P. Interaction between G protein-coupled receptor 143 and tyrosinase: implications for understanding ocular albinism type 1. J Invest Dermatol. 2017;137(2):457\u201365.","journal-title":"J Invest Dermatol"},{"key":"1866_CR24","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15030894","author":"M Vitiello","year":"2023","unstructured":"Vitiello M, Mercatanti A, Podda MS, et al. A network of MicroRNAs and mRNAs involved in melanosome maturation and trafficking defines the lower response of pigmentable melanoma cells to targeted therapy. Cancers (Basel). 2023. https:\/\/doi.org\/10.3390\/cancers15030894.","journal-title":"Cancers (Basel)"},{"issue":"48","key":"1866_CR25","doi-asserted-by":"publisher","first-page":"31801","DOI":"10.1074\/jbc.273.48.31801","volume":"273","author":"T Kobayashi","year":"1998","unstructured":"Kobayashi T, Imokawa G, Bennett DC, et al. Tyrosinase stabilization by Tyrp1 (the brown locus protein). J Biol Chem. 1998;273(48):31801\u20135.","journal-title":"J Biol Chem"},{"issue":"6","key":"1866_CR26","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1034\/j.1600-0749.2001.140603.x","volume":"14","author":"R Sarangarajan","year":"2001","unstructured":"Sarangarajan R, Boissy RE. Tyrp1 and oculocutaneous albinism type 3. Pigment Cell Res. 2001;14(6):437\u201344.","journal-title":"Pigment Cell Res"},{"issue":"11","key":"1866_CR27","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1038\/ncb3623","volume":"19","author":"D Gilot","year":"2017","unstructured":"Gilot D, Migault M, Bachelot L, et al. A non-coding function of TYRP1 mRNA promotes melanoma growth. Nat Cell Biol. 2017;19(11):1348\u201357.","journal-title":"Nat Cell Biol"},{"key":"1866_CR28","doi-asserted-by":"publisher","DOI":"10.3390\/cancers11081061","author":"MF Bakhoum","year":"2019","unstructured":"Bakhoum MF, Esmaeli B. Molecular characteristics of uveal melanoma: insights from the Cancer Genome Atlas (TCGA) project. Cancers (Basel). 2019. https:\/\/doi.org\/10.3390\/cancers11081061.","journal-title":"Cancers (Basel)"},{"issue":"9","key":"1866_CR29","doi-asserted-by":"publisher","first-page":"1874","DOI":"10.1007\/s12094-021-02597-7","volume":"23","author":"J Jha","year":"2021","unstructured":"Jha J, Singh MK, Singh L, et al. Association of TYRP1 with hypoxia and its correlation with patient outcome in uveal melanoma. Clin Transl Oncol. 2021;23(9):1874\u201384.","journal-title":"Clin Transl Oncol"},{"issue":"4","key":"1866_CR30","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1038\/ng1330","volume":"36","author":"H Suzuki","year":"2004","unstructured":"Suzuki H, Watkins DN, Jair KW, et al. Epigenetic inactivation of SFRP genes allows constitutive WNT signaling in colorectal cancer. Nat Genet. 2004;36(4):417\u201322.","journal-title":"Nat Genet"},{"issue":"32","key":"1866_CR31","doi-asserted-by":"publisher","first-page":"4699","DOI":"10.1038\/sj.onc.1210259","volume":"26","author":"M Nojima","year":"2007","unstructured":"Nojima M, Suzuki H, Toyota M, et al. Frequent epigenetic inactivation of SFRP genes and constitutive activation of Wnt signaling in gastric cancer. Oncogene. 2007;26(32):4699\u2013713.","journal-title":"Oncogene"},{"key":"1866_CR32","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1186\/1471-2407-7-126","volume":"7","author":"J Huang","year":"2007","unstructured":"Huang J, Zhang YL, Teng XM, et al. Down-regulation of SFRP1 as a putative tumor suppressor gene can contribute to human hepatocellular carcinoma. BMC Cancer. 2007;7:126.","journal-title":"BMC Cancer"},{"issue":"4","key":"1866_CR33","doi-asserted-by":"publisher","first-page":"151","DOI":"10.3727\/096504008785114110","volume":"17","author":"KO Uhm","year":"2008","unstructured":"Uhm KO, Lee ES, Lee YM, et al. Aberrant promoter CpG islands methylation of tumor suppressor genes in cholangiocarcinoma. Oncol Res. 2008;17(4):151\u20137.","journal-title":"Oncol Res"},{"issue":"2","key":"1866_CR34","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1002\/ijc.23957","volume":"124","author":"HY Su","year":"2009","unstructured":"Su HY, Lai HC, Lin YW, et al. An epigenetic marker panel for screening and prognostic prediction of ovarian cancer. Int J Cancer. 2009;124(2):387\u201393.","journal-title":"Int J Cancer"},{"issue":"17","key":"1866_CR35","doi-asserted-by":"publisher","first-page":"6815","DOI":"10.1158\/0008-5472.CAN-09-1254","volume":"69","author":"S Saini","year":"2009","unstructured":"Saini S, Liu J, Yamamura S, et al. Functional significance of secreted frizzled-related protein 1 in metastatic renal cell carcinomas. Cancer Res. 2009;69(17):6815\u201322.","journal-title":"Cancer Res"},{"issue":"5","key":"1866_CR36","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1038\/s41591-018-0014-x","volume":"24","author":"M Binnewies","year":"2018","unstructured":"Binnewies M, Roberts EW, Kersten K, et al. Understanding the tumor immune microenvironment (TIME) for effective therapy. Nat Med. 2018;24(5):541\u201350.","journal-title":"Nat Med"},{"issue":"2","key":"1866_CR37","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.pathol.2015.12.006","volume":"48","author":"N Lee","year":"2016","unstructured":"Lee N, Zakka LR, Mihm MC Jr, et al. Tumour-infiltrating lymphocytes in melanoma prognosis and cancer immunotherapy. Pathology. 2016;48(2):177\u201387.","journal-title":"Pathology"},{"key":"1866_CR38","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.713569","volume":"9","author":"H Zhao","year":"2021","unstructured":"Zhao H, Chen Y, Shen P, et al. Identification of immune cell infiltration landscape and their prognostic significance in uveal melanoma. Front Cell Dev Biol. 2021;9:713569.","journal-title":"Front Cell Dev Biol"},{"issue":"7637","key":"1866_CR39","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1038\/nature21349","volume":"541","author":"DS Chen","year":"2017","unstructured":"Chen DS, Mellman I. Elements of cancer immunity and the cancer-immune set point. Nature. 2017;541(7637):321\u201330.","journal-title":"Nature"},{"key":"1866_CR40","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1146\/annurev-immunol-070621-030155","volume":"40","author":"MD Vesely","year":"2022","unstructured":"Vesely MD, Zhang T, Chen L. Resistance mechanisms to anti-PD cancer immunotherapy. Annu Rev Immunol. 2022;40:45\u201374.","journal-title":"Annu Rev Immunol"},{"issue":"11","key":"1866_CR41","doi-asserted-by":"publisher","first-page":"2690","DOI":"10.1016\/j.cell.2024.04.015","volume":"187","author":"C Wang","year":"2024","unstructured":"Wang C, Zeng Q, G\u00fcl ZM, et al. Circadian tumor infiltration and function of CD8(+) T cells dictate immunotherapy efficacy. Cell. 2024;187(11):2690-2702.e17.","journal-title":"Cell"},{"issue":"1","key":"1866_CR42","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s12943-021-01479-4","volume":"21","author":"T Jiang","year":"2022","unstructured":"Jiang T, Chen J, Xu X, et al. On-treatment blood TMB as predictors for camrelizumab plus chemotherapy in advanced lung squamous cell carcinoma: biomarker analysis of a phase III trial. Mol Cancer. 2022;21(1):4.","journal-title":"Mol Cancer"},{"key":"1866_CR43","doi-asserted-by":"publisher","first-page":"1291938","DOI":"10.3389\/fimmu.2024.1291938","volume":"15","author":"J Wei","year":"2024","unstructured":"Wei J, Ge X, Qian Y, et al. Development and verification of a combined immune- and cancer-associated fibroblast related prognostic signature for colon adenocarcinoma. Front Immunol. 2024;15:1291938.","journal-title":"Front Immunol"}],"container-title":["Clinical and Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-025-01866-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10238-025-01866-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-025-01866-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T02:48:37Z","timestamp":1771037317000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10238-025-01866-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,5]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1866"],"URL":"https:\/\/doi.org\/10.1007\/s10238-025-01866-x","relation":{},"ISSN":["1591-9528"],"issn-type":[{"value":"1591-9528","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,5]]},"assertion":[{"value":"12 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 February 2026","order":6,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":7,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The original online version of this article was revised: due to incorrect Supplementary figure 2 caption and missing Supplementary Figure 3 caption has been updated","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"100"}}